Streetbeat News

Earnings

GLASF

Glass House Brands Inc. reported strong financial results for Q3 2023, with a 71% year-over-year increase in net sales to $48.2 million and a gross profit of $26 million. The company achieved a record low production cost of $118 per pound and attended various conferences. It also appointed new board members and settled an agreement with Element 7, APB, and GH Group. The stock (OTCQX:GLASF) was up 3.79% at $4.65 per share.

Portfolio Pulse from Joana Scopel

November 13, 2023 | 11:17 pm

AIRT

Air T (NASDAQ:AIRT) reported a larger Q2 loss of $(0.57) per share compared to $(0.43) per share in the same quarter last year, despite a 30.15% increase in sales to $79.00M from $60.70M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:05 pm

FFIE

Faraday Future (NASDAQ:FFIE) reported a Q3 2023 EPS of $(3.78), missing the $(3.00) estimate by 26%, and sales of $551.00K, missing the $1.50M estimate by 63.27%. Despite the miss, the loss per share improved by 84.25% compared to the $(24.00) per share loss in the same period last year.

Portfolio Pulse from vinayak@benzinga.com

November 13, 2023 | 11:05 pm

LUCD

Lucid Diagnostics (NASDAQ:LUCD) reported Q3 adjusted EPS of $(0.22), surpassing the $(0.27) estimate, and sales of $783K, slightly beating the $780K estimate. This reflects a significant improvement from the same period last year, with a 21.43% decrease in losses and a 930.26% increase in sales.

Portfolio Pulse from mahesh@benzinga.com

November 13, 2023 | 10:54 pm

CKPT

Checkpoint Therapeutics reported a Q3 EPS of $(0.29), which is an improvement from the $(1.20) reported in the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:50 pm

TIL

Instil Bio (NASDAQ:TIL) reported a Q3 adjusted EPS loss of $(0.16), missing the analyst consensus estimate of $(0.10) by 60%. However, this represents a 62.79% improvement from the $(0.43) per share loss in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:50 pm

CKPT

Checkpoint Therapeutics (NASDAQ:CKPT) reported Q3 earnings with a loss of $(0.29) per share, surpassing the $(0.72) estimate, marking a 59.72% beat and a 75.83% improvement from last year's $(1.20) loss. Sales reached $31.00K, exceeding the $10.00K estimate by 210% but showing a 35.42% decline from the previous year's $48.00K.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:49 pm

TIL

Instil Bio reported a Q3 EPS of $(0.52), a decrease from $(0.43) year-over-year, indicating a widening loss.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:48 pm

AAME

Atlantic American Corporation (NASDAQ:AAME) reported a significant increase in Q3 earnings per share (EPS) to $0.08, up from a loss of $(0.04) in the same quarter last year. However, sales decreased by 3.78% to $44.59 million from $46.34 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:46 pm

NVGS

Navigator Holdings (NYSE:NVGS) reported Q3 earnings per share of $0.26, missing the consensus estimate of $0.29 by 10.34%. However, the company saw a significant increase of 766.67% in earnings compared to $0.03 per share from the same period last year. Sales for the quarter were $137.77M, surpassing the estimate of $122.07M by 12.86% and marking a 28.98% increase from last year's $106.81M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:46 pm